Annual Working Capital
$109.54 M
-$8.74 M-7.39%
December 31, 2023
Summary
- As of February 7, 2025, ABUS annual working capital is $109.54 million, with the most recent change of -$8.74 million (-7.39%) on December 31, 2023.
- During the last 3 years, ABUS annual working capital has fallen by -$8.62 million (-7.30%).
- ABUS annual working capital is now -36.79% below its all-time high of $173.30 million, reached on December 31, 2015.
Performance
ABUS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$113.85 M
-$11.77 M-9.37%
September 30, 2024
Summary
- As of February 7, 2025, ABUS quarterly working capital is $113.85 million, with the most recent change of -$11.77 million (-9.37%) on September 30, 2024.
- Over the past year, ABUS quarterly working capital has dropped by -$1.72 million (-1.49%).
- ABUS quarterly working capital is now -47.02% below its all-time high of $214.89 million, reached on March 31, 2015.
Performance
ABUS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ABUS Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -7.4% | -1.5% |
3 y3 years | -7.3% | -3.7% |
5 y5 years | -7.2% | -3.7% |
ABUS Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -26.7% | at low | -23.8% | +3.9% |
5 y | 5-year | -26.7% | +27.4% | -23.8% | +52.6% |
alltime | all time | -36.8% | >+9999.0% | -47.0% | >+9999.0% |
Arbutus Biopharma Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $113.85 M(-9.4%) |
Jun 2024 | - | $125.63 M(+8.7%) |
Mar 2024 | - | $115.58 M(+5.5%) |
Dec 2023 | $109.54 M(-7.4%) | $109.54 M(-8.2%) |
Sep 2023 | - | $119.28 M(-11.2%) |
Jun 2023 | - | $134.27 M(+5.1%) |
Mar 2023 | - | $127.70 M(+8.0%) |
Dec 2022 | $118.28 M(-20.8%) | $118.28 M(+4.1%) |
Sep 2022 | - | $113.63 M(-11.2%) |
Jun 2022 | - | $127.97 M(-8.8%) |
Mar 2022 | - | $140.29 M(-6.1%) |
Dec 2021 | $149.44 M(+26.5%) | $149.44 M(+28.4%) |
Sep 2021 | - | $116.42 M(+56.0%) |
Jun 2021 | - | $74.63 M(-42.9%) |
Mar 2021 | - | $130.65 M(+10.6%) |
Dec 2020 | $118.16 M(+37.4%) | $118.16 M(+4.0%) |
Sep 2020 | - | $113.63 M(+43.5%) |
Jun 2020 | - | $79.21 M(-6.0%) |
Mar 2020 | - | $84.30 M(-2.0%) |
Dec 2019 | $86.00 M(-27.1%) | $86.00 M(+0.6%) |
Sep 2019 | - | $85.52 M(-5.8%) |
Jun 2019 | - | $90.78 M(-12.4%) |
Mar 2019 | - | $103.66 M(-12.1%) |
Dec 2018 | $117.99 M(+2.8%) | $117.99 M(-10.2%) |
Sep 2018 | - | $131.36 M(-10.2%) |
Jun 2018 | - | $146.23 M(-11.3%) |
Mar 2018 | - | $164.79 M(+43.6%) |
Dec 2017 | $114.74 M(-5.9%) | $114.74 M(+38.9%) |
Sep 2017 | - | $82.58 M(-12.2%) |
Jun 2017 | - | $94.04 M(-14.0%) |
Mar 2017 | - | $109.40 M(-10.3%) |
Dec 2016 | $121.98 M(-29.6%) | $121.98 M(-14.9%) |
Sep 2016 | - | $143.42 M(-9.2%) |
Jun 2016 | - | $158.00 M(-3.4%) |
Mar 2016 | - | $163.65 M(-5.6%) |
Dec 2015 | $173.30 M(+80.1%) | $173.30 M(-6.9%) |
Sep 2015 | - | $186.20 M(-6.7%) |
Jun 2015 | - | $199.57 M(-7.1%) |
Mar 2015 | - | $214.89 M(+123.4%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2014 | $96.21 M(+66.4%) | $96.21 M(+4.3%) |
Sep 2014 | - | $92.25 M(-9.3%) |
Jun 2014 | - | $101.75 M(-10.7%) |
Mar 2014 | - | $113.96 M(+97.1%) |
Dec 2013 | $57.82 M(+43.5%) | $57.82 M(+103.1%) |
Sep 2013 | - | $28.47 M(-12.8%) |
Jun 2013 | - | $32.65 M(-11.3%) |
Mar 2013 | - | $36.82 M(-8.6%) |
Dec 2012 | $40.29 M(+755.5%) | $40.29 M(<-9900.0%) |
Sep 2012 | - | -$192.40 K(-106.2%) |
Jun 2012 | - | $3.09 M(-37.5%) |
Mar 2012 | - | $4.95 M(+5.2%) |
Dec 2011 | $4.71 M(-51.8%) | $4.71 M(-22.9%) |
Sep 2011 | - | $6.11 M(-21.7%) |
Jun 2011 | - | $7.80 M(+9.7%) |
Mar 2011 | - | $7.11 M(-27.3%) |
Dec 2010 | $9.77 M(-46.5%) | $9.77 M(+10.5%) |
Sep 2010 | - | $8.84 M(-17.3%) |
Jun 2010 | - | $10.69 M(-27.4%) |
Mar 2010 | - | $14.74 M(-19.4%) |
Dec 2009 | $18.28 M(-21.5%) | $18.28 M(-10.3%) |
Sep 2009 | - | $20.39 M(-2.6%) |
Jun 2009 | - | $20.94 M(+1.5%) |
Mar 2009 | - | $20.64 M(-11.3%) |
Dec 2008 | $23.28 M(+38.3%) | $23.28 M(-20.9%) |
Sep 2008 | - | $29.41 M(-8.7%) |
Jun 2008 | - | $32.20 M(+108.1%) |
Mar 2008 | - | $15.47 M(-8.1%) |
Dec 2007 | $16.83 M(-6127.9%) | $16.83 M(-4.9%) |
Sep 2007 | - | $17.70 M(+10.2%) |
Jun 2007 | - | $16.05 M |
Dec 2006 | -$279.20 K(-103.2%) | - |
Dec 2005 | $8.71 M(-50.9%) | - |
Dec 2004 | $17.73 M(-50.1%) | - |
Dec 2003 | $35.56 M(-24.1%) | - |
Dec 2001 | $46.87 M(+100.8%) | - |
Dec 2000 | $23.34 M(+23.0%) | - |
Dec 1999 | $18.97 M(+216.8%) | - |
Dec 1998 | $5.99 M | - |
FAQ
- What is Arbutus Biopharma annual working capital?
- What is the all time high annual working capital for Arbutus Biopharma?
- What is Arbutus Biopharma annual working capital year-on-year change?
- What is Arbutus Biopharma quarterly working capital?
- What is the all time high quarterly working capital for Arbutus Biopharma?
- What is Arbutus Biopharma quarterly working capital year-on-year change?
What is Arbutus Biopharma annual working capital?
The current annual working capital of ABUS is $109.54 M
What is the all time high annual working capital for Arbutus Biopharma?
Arbutus Biopharma all-time high annual working capital is $173.30 M
What is Arbutus Biopharma annual working capital year-on-year change?
Over the past year, ABUS annual working capital has changed by -$8.74 M (-7.39%)
What is Arbutus Biopharma quarterly working capital?
The current quarterly working capital of ABUS is $113.85 M
What is the all time high quarterly working capital for Arbutus Biopharma?
Arbutus Biopharma all-time high quarterly working capital is $214.89 M
What is Arbutus Biopharma quarterly working capital year-on-year change?
Over the past year, ABUS quarterly working capital has changed by -$1.72 M (-1.49%)